通过基-1-酸盐受体5激活,对大麻素受体2诱导的瘤发生效应的负调节
1Department of Life Science, Kyonggi University, Suwon, Gyeonggi 16227, Republic of Korea.
Oncology reports
|February 7, 2025
概括
大麻素受体2 (CB2) 和黄素-1-酸盐受体5 (S1P5) 之间的交叉声会影响结质瘤的进展. 激活S1P5会负面调节CB2驱动的瘤细胞增殖和迁移.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- G蛋白结合受体 (GPCRs) 传递细胞外信号. 2型大麻素受体 (CB2) 和5型斯芬戈-1-酸盐受体 (S1P5) 是涉及癌症进展的GPCR.
- 结质瘤瘤细胞增殖和迁移中的CB2和S1P5之间的相互作用仍然不清楚.
研究的目的:
- 研究结质瘤中CB2和S1P5受体之间的相互作用和功能交叉.
- 为了确定CB2和S1P5协同激活对质瘤细胞增殖和迁移的影响.
主要方法:
- 生物发光共振能量转移 (BRET) 来评估受体相互作用.
- 同焦点显微镜用于分析受体的同定位和内部化.
- 使用U-87 MG质母细胞瘤细胞进行细胞增殖和迁移测定.
主要成果:
- S1P5 特别与 CB2 相互作用,两种受体在等离子体膜上同定位,并在激活时同内部化.
- CB2激活增加了质瘤细胞的增殖和迁移.
- S1P5协同激活减弱了CB2诱导的增殖和迁移,降低了关键瘤进展基因的调节.
结论:
- 在质瘤中,S1P5负面调节CB2介导的瘤进展.
- 证据表明CB2和S1P5受体之间的功能交叉声提供了质瘤的潜在治疗点.
相关概念视频
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Amplifying Signals via Enzymatic Cascade
8.2K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Positive Regulator Molecules
105.7K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
105.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


